-
Trump's tariffs could raise the cost of generic drugs in the U.S.
The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.
-
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.
-
Surgeons in Philadelphia successfully separate conjoined twin boys
After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.
-
Remember the prescription drug shortages from last year? The problem hasn't gone away
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.
-
-
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.
-
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.